Desenvolvimento de sistemas multiparticulados de liberação imediata e modificada para associação de fármacos anti-hipertensivos

Desenvolvimento de sistemas multiparticulados de liberação imediata e modificada para associação de fármacos anti-hipertensivos

Os sistemas multiparticulados são aqueles nos quais a dose do fármaco está dividida em pequenas unidades funcionais, tendo assim, uma série de vantagens sobre os sistemas monolíticos convencionais. Este trabalho teve por objetivo desenvolver formulações multiparticuladas de uso oral para fármaco...

Full description

Bibliographic Details
Main Author:	Michéle Georges Issa
Other Authors:	Humberto Gomes Ferraz
Language:	Portuguese
Published:	Universidade de São Paulo 2016
Subjects:	Extrusão a quente Hidroclorotiazida Hipertensão Multiparticulados Olmesartana medoxomila Succinato de metoprolol Hot melt extrusion Hydrochlorothiazide Hypertension Metoprolol succinate Multiparticulate Olmesartan medoxomil
Online Access:	http://www.teses.usp.br/teses/disponiveis/9/9139/tde-19022016-085341/

Similar Items

Desenvolvimento de sistemas multiparticulados de liberação imediata e modificada para associação de fármacos anti-hipertensivos
by: Issa, Michéle Georges
Published: (2016)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?
by: E. V. Kuleshova
Published: (2016-01-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

Effects of Metoprolol on Experimental Spinal Cord Ischemia-Reperfusion Injury in Rats
by: Serap Ozer Yaman, et al.
Published: (2021-01-01)

The new widely discussed clinically significant aspects influence of β-blockers
by: G P Arutyunov
Published: (2013-03-01)

Sistemas multiparticulados: minicomprimidos
by: A.P.N.A. Zerbini, et al.
Published: (2011-05-01)

Desenvolvimento e validação de métodos analíticos para determinação simultânea de fármacos que atuam no controle da hipertensão arterial
by: Claudia Vilela de Oliveira
Published: (2015)

Desenvolvimento e validação de métodos analíticos para determinação simultânea de fármacos que atuam no controle da hipertensão arterial
by: Oliveira, Claudia Vilela de
Published: (2015)

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
by: Luis M Ruilope
Published: (2008-12-01)

Simultaneous quantitative analysis of olmesartan, amlodipine and hydrochlorothiazide in their combined dosage form utilizing classical and alternating least squares based chemometric methods
by: Darwish Hany W., et al.
Published: (2016-03-01)

Obten??o de sistemas multiparticulados de isoniazida revestidos com pol?mero de libera??o ent?rica
by: Freire, F?tima Duarte
Published: (2014)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)

Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)

The role of b-blockers in treatment of hypertension, according to Russian and European experts
by: O D Ostroumova, et al.
Published: (2016-03-01)

The role of b-blockers in treatment of hypertension, according to Russian and European experts
by: Ostroumova O.D., et al.
Published: (2016-01-01)

Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica
by: Bajerski, Lisiane
Published: (2011)

Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica
by: Bajerski, Lisiane
Published: (2011)

Olmesartana medoxomila : validação de metodologia analítica, avaliação biofarmacêutica e análise polimórfica
by: Bajerski, Lisiane
Published: (2011)

ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1)
by: M. G Bubnova
Published: (2014-12-01)

Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2)
by: M. G Bubnova
Published: (2015-03-01)

Influência do etilbenzeno na farmacocinética enantiosseletiva do metoprolol em ratos
by: Fernanda Silva Graciani
Published: (2009)

Influência do etilbenzeno na farmacocinética enantiosseletiva do metoprolol em ratos
by: Graciani, Fernanda Silva
Published: (2009)

Effect of the Surface Hydrophobicity Degree on the <i>In Vitro</i> Release of Polar and Non-Polar Drugs from Polyelectrolyte Matrix Tablets
by: Cristhian J. Yarce, et al.
Published: (2018-11-01)

Measurements, Thermodynamic Modeling, and a Hydrogen Bonding Study on the Solubilities of Metoprolol Succinate in Organic Solvents
by: Jian Shen, et al.
Published: (2018-09-01)

Development and in vitro evaluation of sustained release multiparticulate tablet of freely water soluble drug
by: Ashlesha Pravin Pandit, et al.
Published: (2010-09-01)

Efficacy of metoprolol in treatment and preventive of cardiovascular diseases
by: Irina Evgen'evna Chazova, et al.
Published: (2009-06-01)

Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug
by: Benjamin Berger, et al.
Published: (2018-07-01)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
by: Omboni S, et al.
Published: (2015-10-01)

Assessment of glucolipid metabolism, oxidation and inflammation in patients with diabetic nephropathy after probucol combined with olmesartan medoxomil therapy
by: Yan-Ni Li, et al.
Published: (2016-11-01)

Bioanalytical method development and validation for determination of metoprolol tartarate and hydrochlorothiazide using HPTLC in human plasma
by: Ambadas Ranganath Rote, et al.
Published: (2013-12-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

Interaction of Palmitic Acid with Metoprolol Succinate at the Binding Sites of Bovine Serum Albumin
by: Mashiur Rahman, et al.
Published: (2014-12-01)

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study
by: Mahvash Iram, et al.
Published: (2016-01-01)

Suicide by intravenous injection of rocuronium-bromide: Case report
by: Nikolić Slobodan, et al.
Published: (2005-01-01)

DETERMINATION OF METOPROLOL IN PURE AND PHARMACEUTICAL DOSAGE FORMS BY SPECTROFLUOROMETRY AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
by: BILAL YILMAZ, et al.
Published: (2011-03-01)

Which one is the first choice for rapid ventricular rate atrial fibrillation in emergency department: Metoprolol or Diltiazem? A randomized clinical trial
by: Rohat Ak, et al.
Published: (2019-01-01)

Hiperpigmentação da Face Induzida por Tratamento com Olmesartan Medoxomilo-Hidroclorotiazida
by: Miguel Costa-Silva, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_9agf5sg079i14tt0e7lik62blm